Diarrhea during chemotherapy and its complications


Diarrhea is more common than constipation and produces more deleterious effects. Otherwise promptly managed, diarrhea can result in serious problems for example dehydration, electrolyte imbalances, weakness, lethargy, and metabolic acidosis.

Diarrhea may be the passage of frequent and watery stools, in this context caused by the destruction of the GI epithelium by chemotherapeutic agents. Diarrhea is usually related to antimetabolite administration and it is a dose-limiting factor for 5-fluorouracil and irinotecan.

Other reasons for diarrhea, for example infection, intestinal obstruction, laxative abuse, and hypocalcemia, should be eliminated before initiating treatment.

Diarrhea is better managed by pharmacologic intervention with anticholinergic drugs and opiates. Octreotide, a reliable analogue of somatostatin, indicates efficacy because of its antisecretory effect in chemotherapy-induced diarrhea.

Patient education and chemotherapy

Measure the patient for indications of diarrhea and dehydration. Review these using the patient therefore the patient can monitor and self-report. Assess bowel function and elimination pattern. Monitor weight, intake and output, and electrolytes. Administer IV fluids or electrolytes as ordered.

Administer antidiarrheal medications as ordered. Explain medications towards the patient. Let the patient to consume a low-residue, high-protein, high-calorie diet, increase fluid intake, and steer clear of foods for example beans, peas, milk, and caffeine.

Avoid spicy and fats, alcohol, and tobacco. Instruct the individual to rehearse good perianal hygiene after each episode of diarrhea. Encourage rest and decreased activity. Consider discontinuing the drug or modifying the dose if diarrhea persists.

Legal Disclaimer

Our website is not responsible for the information contained by this article. Webworldarticles.com is a free articles resource thus practically any visitor can submit an article. However if you notice any copyrighted material, please contact us and we will remove the article(s) in discussion right away.


This article was sent to us by: Duane Owens at 07262011

Related Articles

1. Alkylating agents used in chemotherapy to fight cancer cells
Alkylating agents Alkylating agents alter DNA structure with the poorly understood procedure for alkylation, which ends in cross-linking and strand breaking of DN...

2. Chemotherapy and Biologic Response Modifiers in cancer treatment
Biologic treatments are your fourth modality in the treatment of cancer, after surgery, chemotherapy, and radiation. Biologic therapy produces anticancer effects through ei...

3. Immunotoxin therapy and chemotherapy in cancer treatment
Immunotoxin therapy continues to be designed to deliver toxins towards the tumor cell to result in cell death. Toxins used are incredibly potent bacterial or plant products...

4. Hematopoietic growth factors and chemotherapy in cancer treatment
Hematopoietic growth factors are naturally sourced hormone-like glycoproteins that regulate the proliferation, differentiation, and maturation of blood cells by binding to ...

5. Vaccine and gene therapy in various malignancies
Vaccine therapy Vaccine therapy continues to be studied in various malignancies for example breast, melanoma, colon, and lung cancers. The introduction of tumor v...

6. Chemotherapy progress and drug development in cancer treatment
Based on federal regulations governing the security of human subjects, scientific studies are "the systematic investigation, including research development, testing, and ev...

7. Chemotherapy pretreatment patient and family assessment
Before a chemotherapy treatment is initiated, the professional accountable for the administration of the agent must independently measure the patient. This pretreatment ass...